Cutaneous group B streptococcal infection: Difference between revisions
No edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Cutaneous group B streptococcal infection | |||
| synonyms = [[Streptococcus agalactiae]] skin infection | |||
| field = [[Dermatology]], [[Infectious disease]] | |||
| symptoms = [[Cellulitis]], [[erysipelas]], [[abscess]]es, [[ulcer]]s | |||
| complications = [[Sepsis]], [[necrotizing fasciitis]] | |||
| onset = Any age, more common in [[neonates]] and [[elderly]] | |||
| duration = Varies, depending on treatment | |||
| causes = [[Streptococcus agalactiae]] | |||
| risks = [[Diabetes mellitus]], [[immunocompromised]] state, [[pregnancy]] | |||
| diagnosis = [[Clinical diagnosis]], [[bacterial culture]] | |||
| differential = [[Staphylococcal skin infection]], [[cellulitis]] from other causes | |||
| prevention = Good [[hygiene]], managing [[chronic conditions]] | |||
| treatment = [[Antibiotics]] such as [[penicillin]], [[amoxicillin]] | |||
| medication = [[Antibiotics]] | |||
| prognosis = Good with treatment, but can be severe in [[immunocompromised]] | |||
| frequency = Less common than other [[streptococcal infections]] | |||
}} | |||
'''Cutaneous Group B Streptococcal Infection''' is a type of bacterial infection caused by the bacterium ''[[Streptococcus agalactiae]]'', commonly known as Group B Streptococcus (GBS). This condition specifically affects the skin, leading to various symptoms and complications if not treated promptly. GBS is known for its role in neonatal infections but can also affect adults, particularly those with compromised immune systems or existing skin damage. | '''Cutaneous Group B Streptococcal Infection''' is a type of bacterial infection caused by the bacterium ''[[Streptococcus agalactiae]]'', commonly known as Group B Streptococcus (GBS). This condition specifically affects the skin, leading to various symptoms and complications if not treated promptly. GBS is known for its role in neonatal infections but can also affect adults, particularly those with compromised immune systems or existing skin damage. | ||
==Symptoms and Diagnosis== | ==Symptoms and Diagnosis== | ||
The symptoms of cutaneous GBS infection can vary but often include redness, swelling, tenderness, and the presence of blisters or ulcers on the skin. In severe cases, the infection can lead to systemic symptoms such as fever, chills, and malaise. Diagnosis typically involves the collection of a skin swab or tissue biopsy, which is then cultured to identify the presence of GBS. In some cases, blood tests may also be conducted to check for signs of systemic infection. | The symptoms of cutaneous GBS infection can vary but often include redness, swelling, tenderness, and the presence of blisters or ulcers on the skin. In severe cases, the infection can lead to systemic symptoms such as fever, chills, and malaise. Diagnosis typically involves the collection of a skin swab or tissue biopsy, which is then cultured to identify the presence of GBS. In some cases, blood tests may also be conducted to check for signs of systemic infection. | ||
==Transmission and Risk Factors== | ==Transmission and Risk Factors== | ||
Cutaneous GBS infection is primarily transmitted through direct contact with the bacteria, which can occur through breaks in the skin or mucous membranes. Individuals at higher risk include newborns, particularly those born to mothers who are colonized with GBS, and adults with chronic health conditions such as diabetes or those with weakened immune systems. Skin injuries, surgical wounds, and the use of invasive medical devices can also increase the risk of infection. | Cutaneous GBS infection is primarily transmitted through direct contact with the bacteria, which can occur through breaks in the skin or mucous membranes. Individuals at higher risk include newborns, particularly those born to mothers who are colonized with GBS, and adults with chronic health conditions such as diabetes or those with weakened immune systems. Skin injuries, surgical wounds, and the use of invasive medical devices can also increase the risk of infection. | ||
==Treatment and Prevention== | ==Treatment and Prevention== | ||
Treatment for cutaneous GBS infection typically involves the use of antibiotics to eliminate the bacteria. In cases of mild skin infection, oral antibiotics may be sufficient, while more severe or systemic infections may require intravenous administration. Prevention strategies include routine screening for GBS colonization in pregnant women and the use of intrapartum antibiotic prophylaxis to prevent neonatal infection. Good wound care and hygiene practices can also reduce the risk of cutaneous GBS infection in adults. | Treatment for cutaneous GBS infection typically involves the use of antibiotics to eliminate the bacteria. In cases of mild skin infection, oral antibiotics may be sufficient, while more severe or systemic infections may require intravenous administration. Prevention strategies include routine screening for GBS colonization in pregnant women and the use of intrapartum antibiotic prophylaxis to prevent neonatal infection. Good wound care and hygiene practices can also reduce the risk of cutaneous GBS infection in adults. | ||
==Complications== | ==Complications== | ||
If left untreated, cutaneous GBS infection can lead to serious complications, including the spread of the infection to deeper tissues or the bloodstream, resulting in conditions such as [[cellulitis]], [[necrotizing fasciitis]], or [[bacteremia]]. These complications can be life-threatening and require immediate medical intervention. | If left untreated, cutaneous GBS infection can lead to serious complications, including the spread of the infection to deeper tissues or the bloodstream, resulting in conditions such as [[cellulitis]], [[necrotizing fasciitis]], or [[bacteremia]]. These complications can be life-threatening and require immediate medical intervention. | ||
Latest revision as of 06:02, 4 April 2025
| Cutaneous group B streptococcal infection | |
|---|---|
| Synonyms | Streptococcus agalactiae skin infection |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Cellulitis, erysipelas, abscesses, ulcers |
| Complications | Sepsis, necrotizing fasciitis |
| Onset | Any age, more common in neonates and elderly |
| Duration | Varies, depending on treatment |
| Types | N/A |
| Causes | Streptococcus agalactiae |
| Risks | Diabetes mellitus, immunocompromised state, pregnancy |
| Diagnosis | Clinical diagnosis, bacterial culture |
| Differential diagnosis | Staphylococcal skin infection, cellulitis from other causes |
| Prevention | Good hygiene, managing chronic conditions |
| Treatment | Antibiotics such as penicillin, amoxicillin |
| Medication | Antibiotics |
| Prognosis | Good with treatment, but can be severe in immunocompromised |
| Frequency | Less common than other streptococcal infections |
| Deaths | N/A |
Cutaneous Group B Streptococcal Infection is a type of bacterial infection caused by the bacterium Streptococcus agalactiae, commonly known as Group B Streptococcus (GBS). This condition specifically affects the skin, leading to various symptoms and complications if not treated promptly. GBS is known for its role in neonatal infections but can also affect adults, particularly those with compromised immune systems or existing skin damage.
Symptoms and Diagnosis[edit]
The symptoms of cutaneous GBS infection can vary but often include redness, swelling, tenderness, and the presence of blisters or ulcers on the skin. In severe cases, the infection can lead to systemic symptoms such as fever, chills, and malaise. Diagnosis typically involves the collection of a skin swab or tissue biopsy, which is then cultured to identify the presence of GBS. In some cases, blood tests may also be conducted to check for signs of systemic infection.
Transmission and Risk Factors[edit]
Cutaneous GBS infection is primarily transmitted through direct contact with the bacteria, which can occur through breaks in the skin or mucous membranes. Individuals at higher risk include newborns, particularly those born to mothers who are colonized with GBS, and adults with chronic health conditions such as diabetes or those with weakened immune systems. Skin injuries, surgical wounds, and the use of invasive medical devices can also increase the risk of infection.
Treatment and Prevention[edit]
Treatment for cutaneous GBS infection typically involves the use of antibiotics to eliminate the bacteria. In cases of mild skin infection, oral antibiotics may be sufficient, while more severe or systemic infections may require intravenous administration. Prevention strategies include routine screening for GBS colonization in pregnant women and the use of intrapartum antibiotic prophylaxis to prevent neonatal infection. Good wound care and hygiene practices can also reduce the risk of cutaneous GBS infection in adults.
Complications[edit]
If left untreated, cutaneous GBS infection can lead to serious complications, including the spread of the infection to deeper tissues or the bloodstream, resulting in conditions such as cellulitis, necrotizing fasciitis, or bacteremia. These complications can be life-threatening and require immediate medical intervention.
